| pubmed-article:8807135 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8807135 | lifeskim:mentions | umls-concept:C0149615 | lld:lifeskim |
| pubmed-article:8807135 | lifeskim:mentions | umls-concept:C0270729 | lld:lifeskim |
| pubmed-article:8807135 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8807135 | pubmed:dateCreated | 1996-11-22 | lld:pubmed |
| pubmed-article:8807135 | pubmed:abstractText | We report a severe case of drug-induced parkinsonism (DIP) after allogeneic BMT successfully treated with levodopa. BMT patients typically receive numerous medications which can cause DIP, and mild cases of DIP may remain unrecognized or be misdiagnosed. Physicians should be aware of DIP as a potential neurological complication after BMT to avoid further administration of drugs that could aggravate symptoms. | lld:pubmed |
| pubmed-article:8807135 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8807135 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8807135 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8807135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8807135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8807135 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8807135 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:8807135 | pubmed:issn | 0268-3369 | lld:pubmed |
| pubmed-article:8807135 | pubmed:author | pubmed-author:BishopM RMR | lld:pubmed |
| pubmed-article:8807135 | pubmed:author | pubmed-author:WszolekZ KZK | lld:pubmed |
| pubmed-article:8807135 | pubmed:author | pubmed-author:MarkopoulouKK | lld:pubmed |
| pubmed-article:8807135 | pubmed:author | pubmed-author:PavleticZ SZS | lld:pubmed |
| pubmed-article:8807135 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8807135 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:8807135 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8807135 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8807135 | pubmed:pagination | 1185-7 | lld:pubmed |
| pubmed-article:8807135 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:meshHeading | pubmed-meshheading:8807135-... | lld:pubmed |
| pubmed-article:8807135 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8807135 | pubmed:articleTitle | Drug-induced parkinsonism after allogeneic bone marrow transplantation. | lld:pubmed |
| pubmed-article:8807135 | pubmed:affiliation | Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA. | lld:pubmed |
| pubmed-article:8807135 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8807135 | pubmed:publicationType | Case Reports | lld:pubmed |
